基于加速康复外科的隐蔽切口单孔胸腔镜手术对自发性气胸的临床疗效  

Clinical efficacy of concealed incision single-hole thoracoscopic surgery based on enhanced recovery after surgery in the treatment of patients with spontaneous pneumothorax

作　　者：陈泉[1] 郑一鸣[1] 王鹏程[1] 贾卫光 陈霞[1] 吴兵兵[1] CHEN Quan;ZHENG Yiming;WANG Pengcheng;JIA Weiguang;CHEN Xia;WU Bingbing(Department of Thoracic Surgery,People′s Hospital of Taizhou City,Taizhou,Jiangsu,225300)

机构地区：[1]江苏省泰州市人民医院胸外科

出　　处：《实用临床医药杂志》2019年第23期98-100,共3页Journal of Clinical Medicine in Practice

摘　　要：目的探讨基于加速康复外科(ERAS)的单孔胸腔镜隐蔽切口手术对于自发性气胸患者的临床疗效。方法选取60例自发性气胸手术患者作为研究对象,手术均在全胸腔镜下进行,将患者随机分为2组,各30例。观察组采用基于ERAS的单孔胸腔镜隐蔽切口手术治疗,对照组采用常规单操作孔胸腔镜手术治疗,比较2组的手术情况、术后疗效及并发症发生情况。结果观察组的住院观察时间、拔管时间、术后下床时间和术后并发症发生率均优于对照组,差异有统计学意义(P<0.05);2组的术中出血量、手术时间比较,差异无统计学意义(P>0.05)。结论采用基于ERAS的单孔胸腔镜隐蔽切口手术治疗自发性气胸患者,不增加手术操作难度,还可提高临床疗效,降低并发症发生率。Objective To investigate the clinical efficacy of concealed incision single-hole thoracoscopic surgery based on enhanced recovery after surgery(ERAS)in the treatment of patients with spontaneous pneumothorax.Methods A total of 60 patients with spontaneous pneumothorax were selected as study objects and were divided into two groups,and thoracoscopic surgeries were performed for these patients.The observation group was given single-hole thoracoscopic surgery by hidden incision,while the control group was given conventional thoracoscopic surgery with a single operating hole.The conditions of surgeries,postoperative clinical curative effects and incidence of complications of the two groups were compared.Results The total incidence of postoperative complications,hospital stay and off-bed activity time,extubation time were better than that in the control groups(P<0.05),while the amount of intraoperative bleeding and operation time showed no significantly differences(P>0.05).Conclusion Single-hole thoracoscopic surgery by concealed incision based on ERAS does not increase operation difficulty,and can improve the clinical curative effect,reduce incidence of complications.

关 键 词：加速康复外科 单孔胸腔镜 隐蔽切口 自发性气胸 临床疗效 

分 类 号：R561.4[医药卫生—呼吸系统]